<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "verapamil inj AMP">
<dose><value>0.1 - 0.2</value>
<value>0.1 - 0.3</value>
<value>2.5 - 5</value>
<value>5 - 10</value>
<value>1 - 5</value>
</dose>
<route><value>IV</value>
<value>IV </value>
</route>
<strength><value>2.5 mg/mL</value>
</strength>
<frequency><value>ONCE</value>
<value>CONTINUOUS</value>
</frequency>
<instruction><value>Administer by direct injection over 2 minutes.</value>
<value>Maintenance infusion: Titrate to desired effect.</value>
</instruction>
<volume><value>2 mL</value>
</volume>
<units><value>mg/kg/dose</value>
<value>mg</value>
<value>mg/hour</value>
<value>mcg/kg/minute</value>
</units>
<Population></Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>INFANT (less than 1 year of age):MAXIMUM: 2 mg/dose. Where required, the dose can be repeated 30 minutes after initial dose.</value>
<value>CHILDREN (1 TO 15 years of age):MAXIMUM: 5 mg/dose. Where required, the dose can be repeated 30 minutes after initial dose. MAXIMUM repeat dose: 10mg.</value>
<value>ADULT: If no response and no adverse event, may give 5 to 10 mg every 15 to 30 minutes to a total dose of 20 to 30 mg.</value>
<value>ADULT.</value>
</AdditionalNotes>
<BackgroundInformation><value>In patients with hepatic cirrhosis, reduce dose to 20% to 50% of normal dose and monitor BP for hypotension and PR prolongation.</value>
<value>In patients with hepatic cirrhosis, reduce dose to 20% to 50% of normal dose and monitor for abnormal PR prolongation or other adverse effects.</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary.</value>
</AHSFormularyStatus>
<AHFSName><value>Calcium-Channel Blocking Agents, Miscellaneous</value>
</AHFSName>
<HighAlert></HighAlert>
</drug>